Eden Research Plc, the AIM-listed natural micro-encapsulation company, announced that it has appointed Robin James Scott Cridland as a Non-Executive Director. Cridland has over 20 years of experience in senior management and transactional roles in the international pharmaceutical and technology sectors, including serving on the boards of listed companies as an executive director.
Cridland currently serves as Chief Financial Officer and Company Secretary of Revolymer plc. He joined Revolymer in September 2008 from Renovo Group where he spent seven years as Executive Director of Finance and Business Development. He has been centrally involved in the listing of both businesses and in a number of significant licences and other product commercialisation deals. Mr Cridland has a first-class honours degree in Natural Sciences from the University of Oxford and is a Fellow of the Institute of Chartered Accountants in England and Wales.